Larson Jeffrey Leroy has filed 3 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 10820 shares of Tvardi Therapeutics, Inc. ($TVRD) on April 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 10820 | $0.00 | 10,820.0000 | 1,524,116 | 9999.99% | 0.71% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 16764 | $0.00 | 16,764.0000 | 1,524,116 | 9999.99% | 1.10% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Larson Jeffrey Leroy | SVP, Research & Development | A | Employee Stock Option (right to buy) | 5364 | $0.00 | 5,364.0000 | 1,524,116 | 9999.99% | 0.35% |